ASCO Preview Highlights Study Of Alimta For First-Line NSCLC
This article was originally published in The Pink Sheet Daily
Executive Summary
Maintenance therapy with Lilly’s pemetrexed shows increase in progression-free survival in the only drug-related abstract in ASCO’s press call.